Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase (original) (raw)

• Goedert, M. & Spillantini, M.G. A century of Alzheimer's disease. Science 314, 777–781 (2006).
  Article CAS Google Scholar
• Faghihi, M.A., Mottagui-Tabar, S. & Wahlestedt, C. Genetics of neurological disorders. Expert Rev. Mol. Diagn. 4, 317–332 (2004).
  Article CAS Google Scholar
• Monaco, S., Zanusso, G., Mazzucco, S. & Rizzuto, N. Cerebral amyloidoses: molecular pathways and therapeutic challenges. Curr. Med. Chem. 13, 1903–1913 (2006).
  Article Google Scholar
• Lacor, P.N. et al. Aβ oligomer–induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci. 27, 796–807 (2007).
  Article CAS Google Scholar
• Zhu, D. et al. Phospholipases A2 mediate amyloid-β peptide–induced mitochondrial dysfunction. J. Neurosci. 26, 11111–11119 (2006).
  Article CAS Google Scholar
• Esposito, G. et al. CB1 receptor selective activation inhibits β-amyloid–induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons. Neurosci. Lett. 404, 342–346 (2006).
  Article CAS Google Scholar
• Snyder, E.M. et al. Regulation of NMDA receptor trafficking by amyloid-β. Nat. Neurosci. 8, 1051–1058 (2005).
  Article CAS Google Scholar
• Matsuyama, S., Teraoka, R., Mori, H. & Tomiyama, T. Inverse correlation between amyloid precursor protein and synaptic plasticity in transgenic mice. Neuroreport 18, 1083–1087 (2007).
  Article CAS Google Scholar
• Abramov, A.Y., Canevari, L. & Duchen, M.R. β-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J. Neurosci. 24, 565–575 (2004).
  Article CAS Google Scholar
• Ohyagi, Y. et al. Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease. FASEB J. 19, 255–257 (2005).
  Article CAS Google Scholar
• Zhao, J. et al. β-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J. Neurosci. 27, 3639–3649 (2007).
  Article CAS Google Scholar
• Sun, X. et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl. Acad. Sci. USA 103, 18727–18732 (2006).
  Article CAS Google Scholar
• Tong, Y. et al. Oxidative stress potentiates BACE1 gene expression and Aβ generation. J. Neural Transm. 112, 455–469 (2005).
  Article CAS Google Scholar
• Li, R. et al. Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients. Proc. Natl. Acad. Sci. USA 101, 3632–3637 (2004).
  Article CAS Google Scholar
• Holsinger, R.M., McLean, C.A., Collins, S.J., Masters, C.L. & Evin, G. Increased β-secretase activity in cerebrospinal fluid of Alzheimer's disease subjects. Ann. Neurol. 55, 898–899 (2004).
  Article Google Scholar
• Fukumoto, H., Cheung, B.S., Hyman, B.T. & Irizarry, M.C. β-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59, 1381–1389 (2002).
  Article Google Scholar
• Johnston, J.A. et al. Expression and activity of β-site amyloid precursor protein cleaving enzyme in Alzheimer's disease. Biochem. Soc. Trans. 33, 1096–1100 (2005).
  Article CAS Google Scholar
• Ohno, M. et al. BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41, 27–33 (2004).
  Article CAS Google Scholar
• Tesco, G. et al. Depletion of GGA3 stabilizes BACE and enhances β-secretase activity. Neuron 54, 721–737 (2007).
  Article CAS Google Scholar
• Ma, H. et al. Involvement of β-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein–mediated enhancement of memory and activity-dependent synaptic plasticity. Proc. Natl. Acad. Sci. USA 104, 8167–8172 (2007).
  Article CAS Google Scholar
• Laird, F.M. et al. BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J. Neurosci. 25, 11693–11709 (2005).
  Article CAS Google Scholar
• Hu, X. et al. Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 9, 1520–1525 (2006).
  Article CAS Google Scholar
• Willem, M. et al. Control of peripheral nerve myelination by the β-secretase BACE1. Science 314, 664–666 (2006).
  Article CAS Google Scholar
• Engstrom, P.G. et al. Complex loci in human and mouse genomes. PLoS Genet. 2, e47 (2006).
  Article Google Scholar
• Katayama, S. et al. Antisense transcription in the mammalian transcriptome. Science 309, 1564–1566 (2005).
  Article Google Scholar
• Wahlestedt, C. Natural antisense and noncoding RNA transcripts as potential drug targets. Drug Discov. Today 11, 503–508 (2006).
  Article CAS Google Scholar
• Su, Y., Ryder, J. & Ni, B. Inhibition of Aβ production and APP maturation by a specific PKA inhibitor. FEBS Lett. 546, 407–410 (2003).
  Article CAS Google Scholar
• Thakker, D.R., Hoyer, D. & Cryan, J.F. Interfering with the brain: use of RNA interference for understanding the pathophysiology of psychiatric and neurological disorders. Pharmacol. Ther. 109, 413–438 (2006).
  Article CAS Google Scholar
• Borghi, R. et al. The increased activity of BACE1 correlates with oxidative stress in Alzheimer's disease. Neurobiol. Aging 28, 1009–1014 (2006).
  Article Google Scholar
• Tamagno, E., Bardini, P., Guglielmotto, M., Danni, O. & Tabaton, M. The various aggregation states of β-amyloid 1–42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. Free Radic. Biol. Med. 41, 202–212 (2006).
  Article CAS Google Scholar
• Harkany, T. et al. Mechanisms of β-amyloid neurotoxicity: perspectives of pharmacotherapy. Rev. Neurosci. 11, 329–382 (2000).
  Article CAS Google Scholar
• Yatin, S.M. et al. Temporal relations among amyloid β-peptide–induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses. J. Mol. Neurosci. 11, 183–197 (1998).
  Article CAS Google Scholar
• Meyer-Luehmann, M. et al. Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease. Nature 451, 720–724 (2008).
  Article CAS Google Scholar
• Walsh, D.M. et al. The role of cell-derived oligomers of Aβ in Alzheimer's disease and avenues for therapeutic intervention. Biochem. Soc. Trans. 33, 1087–1090 (2005).
  Article CAS Google Scholar
• Link, C.D. et al. Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiol. Aging 24, 397–413 (2003).
  Article CAS Google Scholar
• Ray, S. et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13, 1359–1362 (2007).
  Article CAS Google Scholar
• Chishti, M.A. et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276, 21562–21570 (2001).
  Article CAS Google Scholar
• Li, F. et al. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J. Neurochem. 89, 1308–1312 (2004).
  Article CAS Google Scholar
• McConlogue, L. et al. Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice. J. Biol. Chem. 282, 26326–26334 (2007).
  Article CAS Google Scholar
• Zhong, Z. et al. Levels of β-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment. Arch. Gen. Psychiatry 64, 718–726 (2007).
  Article CAS Google Scholar
• Li, Y., Zhou, W., Tong, Y., He, G. & Song, W. Control of APP processing and Aβ generation level by BACE1 enzymatic activity and transcription. FASEB J. 20, 285–292 (2006).
  Article Google Scholar
• Cirrito, J.R. et al. Synaptic activity regulates interstitial fluid amyloid-β levels in vivo. Neuron 48, 913–922 (2005).
  Article CAS Google Scholar
• Emilsson, L., Saetre, P. & Jazin, E. Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol. Dis. 21, 618–625 (2006).
  Article CAS Google Scholar
• Brooks, W.M. et al. Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease. Brain Res. 1127, 127–135 (2007).
  Article CAS Google Scholar
• Rossner, S., Sastre, M., Bourne, K. & Lichtenthaler, S.F. Transcriptional and translational regulation of BACE1 expression–implications for Alzheimer's disease. Prog. Neurobiol. 79, 95–111 (2006).
  Article CAS Google Scholar
• Holsinger, R.M., McLean, C.A., Beyreuther, K., Masters, C.L. & Evin, G. Increased expression of the amyloid precursor β-secretase in Alzheimer's disease. Ann. Neurol. 51, 783–786 (2002).
  Article CAS Google Scholar
• Hsieh, H. et al. AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss. Neuron 52, 831–843 (2006).
  Article CAS Google Scholar
• St Laurent, G., III & Wahlestedt, C. Noncoding RNAs: couplers of analog and digital information in nervous system function? Trends Neurosci. 30, 612–621 (2007).
  Article CAS Google Scholar
• Vassar, R. The β-secretase, BACE: a prime drug target for Alzheimer's disease. J. Mol. Neurosci. 17, 157–170 (2001).
  Article CAS Google Scholar
• Kumar, P. et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 448, 39–43 (2007).
  Article CAS Google Scholar